Menu
Recruiting NCT05601037

LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema

No phase Interventional Lymphedema, Breast Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Axilla dissection + Lymphovenous anastomosis.
Who it may be relevant to
Registry conditions: Lymphedema, Breast Cancer. Basic parameters: 18 years — 99 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Lymfo-Veneuse Anastomosen Ter Preventie Van Lymphoedeem

Overview

Lymphedema is defined as a chronic condition, caused by lymphostasis. A major part in the Western world consists of iatrogenic lymphedema caused by surgery to the lymph nodes of the axilla or groin. Prophylactic lymphovenous anastomosis (LVA) could be beneficial in the prevention of lymphedema of the extremities.

Detailed description

The investigator is performing a blinded randomized prospective study on 80 patients undergoing an axilla dissection for their breast cancer treatment. One group will receive a LVA at the time of their axilla dissection. Other group will receive standard of care. Follow-up is 2 year.

Interventions

  • Procedure Axilla dissection + Lymphovenous anastomosis
    surgical bypass between lymphatic vessel and vein

Primary outcome measures

  • The volume via circumferential measurements: swelling < 5% [Time frame: 2 years]

Eligibility criteria

Inclusion criteria

  • lymph node + breast cancer requiring dissection

Exclusion criteria

  • previous lymphedema
  • BMI >35

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Prevention

Study locations

Belgium · 1 center
  • UZ GENT — Ghent

Publications

  • Depypere B, Vyncke T, Dhooghe N, Claes K, Blondeel P, Van Landuyt K. A Novel Technique for Preventive Lymphovenous Anastomosis: Anastomosing a Ligated Lymphatic Vessel. Plast Reconstr Surg Glob Open. 2021 Mar 22;9(3):e3509. doi: 10.1097/GOX.0000000000003509. eCollection 2021 Mar. PMID 33968557

Identifiers

NCT: NCT05601037 · BC-09374 · 2021-004751-16

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗